| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Specialized Center for Cancer Research and Education, University of Illinois College of Medicine at Chicago, Chicago, Illinois 60612
Two murine monoclonal antibodies, 2913 (IgG1) and 292 (IgG2a), generated against malignant fibrous histiocytoma plasma membranes immunoprecipitated a Mr 200,000 protein (p200), with an isoelectric point between 6.3 and 7.5. Two additional antibodies, 3516 (IgG1) and 3040 (IgG2a), generated against Ewing's sarcoma membranes, immunoprecipitated an acidic protein of Mr 160,000 (p160), with an isoelectric point between 5.8 and 6.7. Monoclonal antibodies 2913 and 292 recognize a similar determinant(s) on p200 while 3516 and 3040 recognize different determinants on p160.
Monoclonal antibody 2913 exhibited significant binding to membranes isolated from fibrosarcoma and aggressive fibromatosis; moderate binding to osteosarcoma, hemangiopericytoma, and malignant fibrous histiocytoma; and minimal to no binding to other soft tissue sarcoma plasma membranes. The p200 protein was not expressed in 16 other malignant tumors and in only 3 of 35 normal human tissue specimens. High levels of p200 were selectively expressed by leiomyosarcoma, Ewing's sarcoma, and fibrosarcoma cells as well as neonatal fibroblasts in vitro, but not by other carcinoma cell lines or B-lymphoblasts.
The p160 protein appeared to be selectively expressed by Ewing's sarcoma with little or no expression on other sarcomas, carcinomas, or normal tissues. However, the p160 antigen was expressed in Ewing's sarcoma, leiomyosarcoma, melanoma, 4 of 9 carcinomas, and neonatal fibroblasts in vitro.
The affinity of MoAbs 2913, 292, 3516, and 3040 ranged from 5.3 x 102 to 4.7 x 109 M-1 for sarcoma membranes with approximately 5 x 104 binding sites/sarcoma cell.
1 Supported by USPHS Grant CA-35354 from the National Cancer Institute.
2 Present address: Centocor, Malvern, PA 19355.
3 To whom requests for reprints should be addressed, at Specialized Center for Cancer Research and Education, University of Illinois College of Medicine at Chicago, 840 South Wood Street, Chicago, IL 60612.
Received 1/28/91. Accepted 5/ 6/91.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |